Medical News

RSS

Aquilion ONE 320-detector row CT system reduces radiation exposure

When pediatric patients are imaged using CT, reducing sedation and radiation dose while maintaining the best possible image quality is paramount in delivering care. To provide patients with high-quality CT exams and a reduction in sedation and radiation dose, leading children's hospitals are installing Toshiba America Medical Systems, Inc.'s Aquilion ONE 320-detector row CT system.

9 Aug 2010

Lexicon Pharmaceuticals updates key progress in clinical pipeline

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated the progress of its drug development programs and reported financial results for the three and six months ended June 30, 2010.

9 Aug 2010

Osteotech second-quarter revenue increases 2% to $24.0 million

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the second quarter ended June 30, 2010.

9 Aug 2010

Study: Catholic, other church-owned health systems show more efficient care than for-profit health systems

A study released today by Thomson Reuters found that Catholic and other church-owned health systems demonstrated significantly better, more efficient care than for-profit health systems.

9 Aug 2010

AOBO announces commercial launch of osteoporosis drug Yi Shen Jian Gu Gel

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the commercial launch of Boke brand Yi Shen Jian Gu Gel ("YSJG" Gel) after successful test marketing in the second quarter of 2010.

9 Aug 2010

American Oriental Bioengineering second-quarter revenue up 8.5%

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the second quarter ended June 30, 2010.

9 Aug 2010

Repros Therapeutics receives positive feedback from FDA for Androxal

Repros Therapeutics Inc. today announced that the Company has received positive written feedback from the FDA (the "Agency") regarding the Company's drug candidate Androxal. The Agency concurred with Repros' indication statement for the use of Androxal in the treatment of secondary hypogonadism in men wishing to preserve fertility.

9 Aug 2010

WellCare reports $128.9 million net loss for second-quarter 2010

WellCare Health Plans, Inc. today reported results for the three and six months ended June 30, 2010. As determined under generally accepted accounting principles, the Company reported a second quarter 2010 net loss of $128.9 million, or $3.05 per diluted share, compared with net income of $37.0 million, or $0.88 per diluted share, for the prior year period.

9 Aug 2010

University library collections, services lead to better research articles and grant proposals

Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, today announced the results of a new international study that demonstrates the value of the academic library to the institution in improving grant proposal and report writing and in helping researchers attract grant income. Of the 8 institutions participating from around the globe, 6 demonstrated a greater than one-to-one (1:1) return in grant funding, with results ranging from 15.54:1 to 0.64:1.

9 Aug 2010

Magnetic relaxometry with heat treatment improves treatment of tumours by nanoparticles

Those who have to fight a powerful enemy must look for allies. This is why physicists from different scientific fields have decided to cooperate with biomedical physicians in order to place the fight against cancer through heat treatment by means of magnetic nanoparticles on a solid, scientific basis. It is the objective of the cooperation to improve the success of the therapy.

9 Aug 2010

New Irish collaborative seaweed cultivation project

Stop anyone in the street and ask them which country is the most famous for eating seaweed, and nine times out of ten, the answer will be "Japan". But did you know that Ireland has at least a 900-year old tradition of eating seaweed!

9 Aug 2010

An overview of SRVP annual meeting

Islamic countries have acknowledged the importance of self-reliance in vaccine production and are committed to establishing closer cooperation towards achieving it, as they ended their 6th Annual Meeting of Self-Reliance in Vaccine Production (SRVP), in Bandung, Indonesia.

9 Aug 2010

Myconostica announces CE marking for MycAssay Aspergillus and Pneumocystis on additional platforms

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead products MycAssay™ Aspergillus and MycAssay™ Pneumocystis on the Roche Lightcycler® 2.0 and Stratagene Mx3000 series platforms.

9 Aug 2010

Cegedim Dendrite, Capgemini to offer software solutions for Life Sciences companies

Cegedim Dendrite, the world's leading provider of pharmaceutical-specific Customer Relationship Management solutions, and Capgemini U.S. LLC ("Capgemini"), one of the world's foremost providers of consulting, technology and outsourcing services, announced an alliance to jointly offer software solutions, consulting and technology services around aggregate spend and customer master data to Life Sciences companies. Through the alliance, Capgemini will provide broad based consulting and implementation services associated with Cegedim Dendrite's AggregateSpend360™ and Nucleus 360™ solutions to pharmaceutical, biotech and medical device companies.

9 Aug 2010

AstraZeneca reaches agreements in principle on monetary terms for SEROQUEL product liability

AstraZeneca announced today that, as of August 9, it had reached agreements in principle on monetary terms with attorneys representing approximately 17,500 SEROQUEL product liability claimants in the United States for approximately $198 million. The agreements in principle are subject to agreement on non-monetary terms.

9 Aug 2010

Obama: Health reform law boosts future of Medicare

The Washington Post: "President Obama on Saturday took credit for placing Medicare on a more certain fiscal path and pledged to American seniors that they would see more help soon paying for drug costs in a direct appeal to an important segment of the midterm electorate. Citing a report issued this week by the Medicare trustees, Obama said the health-care overhaul he pushed through Congress this year has added at least a dozen years to Medicare's solvency".

9 Aug 2010

Remote monitoring of chronic heart failure patients can reduce pressure on resources

Providing patients with chronic heart failure access to remote monitoring, for example by telephone or telemonitoring using wireless technology, reduces deaths and hospitalisations and may provide benefits on health care costs and quality of life. These are the conclusions of a new Cochrane Systematic Review by an international team of researchers.

9 Aug 2010

Apte wins Elkeles Prize for outstanding scientist in field of medicine

Ben-Gurion University of the Negev (BGU) Professor Ron N. Apte has been awarded the 2010 Samuel and Paula Elkeles Prize for Outstanding Scientist in the Field of Medicine.

9 Aug 2010

Allergy shots can cause systemic side effects: Study

Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock.About 30 percent of asthma patients experience improved breathing after receiving a series of injections that desensitize their immune systems to specific irritants, according to the review. The medical term for this treatment protocol is allergen immunotherapy.

9 Aug 2010

Active outreach may enhance kids’ ability to get health insurance

A new review of existing research suggests that health system workers can boost the number of children with medical insurance by providing application materials to parents and helping them fill out the forms.

9 Aug 2010